What this study is
With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.
What's being tested
- Focus group analyses
Intervention · BEHAVIORAL
Focus group audiotapes will be transcribed verbatim, and then entered into the qualitative data software package, NVivo 14 for analysis.
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Prostate Cancer
- Enrolling
- 90 people
- Starts
- 2023-05-01
- Est. completion
- 2027-09-27
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 40 Years – 95 YearsSex MALEHealthy volunteers AcceptedYou may qualify if
- African-American or White men
- Living in a rural or urban areas
- Age 40 to 95 years old
- Able and willing to provide informed consent
- English-speaking
- Willing to participate in the study. This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural. This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.
You can't join if
- Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (3)
3 openContact for every open site
- Clinical Trials Referral Office · Contact855-776-0015mayocliniccancerstudies@mayo.edu
Mayo Clinic
Phoenix, Arizona, United States
- Ewan K. Cobran, PhD · Principal investigator
RecruitingMayo Clinic in Florida
Jacksonville, Florida, United States
- Folakemi Odedina, PhD · Principal investigator
RecruitingMayo Clinic
Rochester, Minnesota, United States
- Christi A. Patten, PhD · Principal investigator
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 22-011303
Principal investigator
Ewan K Cobran, PhD
Mayo Clinic
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.